Ocular Therapeutix Up Over 27%, on Track for Highest Close Since May 2021 -- Data Talk

Dow Jones2025-12-09

Ocular Therapeutix Inc (OCUL) is currently at $15.98, up $3.40 or 27.03%

--Would be highest close since May 7, 2021, when it closed at $16.25

--On pace for largest percent increase since Feb. 22, 2024, when it rose 28.99%

--Currently up four consecutive days; up 42.04% over this period

--Longest winning streak since June 26, 2025, when it rose for four straight trading days

--Best four day stretch since the four days ending Dec. 6, 2023, when it rose 46.37%

--Up 31.52% month-to-date

--Up 87.12% year-to-date

--Down 63.07% from its all-time closing high of $43.27 on March 24, 2015

--Up 70.91% from 52 weeks ago (Dec. 9, 2024), when it closed at $9.35

--Would be a new 52-week closing high

--Up 169.7% from its 52-week closing low of $5.93 on March 3, 2025

--Traded as high as $16.10; highest intraday level since May 10, 2021, when it hit $16.11

--Up 27.98% at today's intraday high; largest intraday percent increase since Feb. 22, 2024, when it rose as much as 31.78%

All data as of 11:25:07 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

December 08, 2025 11:29 ET (16:29 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2590935212?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-09 00:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590935212","market":"hk","top_or_hot":-1,"title":"Ocular Therapeutix Up Over 27%, on Track for Highest Close Since May 2021 -- Data Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  <a href=\"https://laohu8.com/S/OCUL\">Ocular Therapeutix</a> Inc (OCUL) is currently at $15.98, up $3.40 or 27.03% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     --Would be highest close since May 7, 2021, when it closed at $16.25 \n</p>\n<p>\n     --On pace for largest percent increase since Feb. 22, 2024, when it rose 28.99% \n</p>\n<p>\n     --Currently up four consecutive days; up 42.04% over this period \n</p>\n<p>\n     --Longest winning streak since June 26, 2025, when it rose for four straight trading days \n</p>\n<p>\n     --Best four day stretch since the four days ending Dec. 6, 2023, when it rose 46.37% \n</p>\n<p>\n     --Up 31.52% month-to-date \n</p>\n<p>\n     --Up 87.12% year-to-date \n</p>\n<p>\n     --Down 63.07% from its all-time closing high of $43.27 on March 24, 2015 \n</p>\n<p>\n     --Up 70.91% from 52 weeks ago (Dec. 9, 2024), when it closed at $9.35 \n</p>\n<p>\n     --Would be a new 52-week closing high \n</p>\n<p>\n     --Up 169.7% from its 52-week closing low of $5.93 on March 3, 2025 \n</p>\n<p>\n     --Traded as high as $16.10; highest intraday level since May 10, 2021, when it hit $16.11 \n</p>\n<p>\n     --Up 27.98% at today's intraday high; largest intraday percent increase since Feb. 22, 2024, when it rose as much as 31.78% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     All data as of 11:25:07 AM ET \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 08, 2025 11:29 ET (16:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocular Therapeutix Up Over 27%, on Track for Highest Close Since May 2021 -- Data Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcular Therapeutix Up Over 27%, on Track for Highest Close Since May 2021 -- Data Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-12-09 00:29</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  <a href=\"https://laohu8.com/S/OCUL\">Ocular Therapeutix</a> Inc (OCUL) is currently at $15.98, up $3.40 or 27.03% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     --Would be highest close since May 7, 2021, when it closed at $16.25 \n</p>\n<p>\n     --On pace for largest percent increase since Feb. 22, 2024, when it rose 28.99% \n</p>\n<p>\n     --Currently up four consecutive days; up 42.04% over this period \n</p>\n<p>\n     --Longest winning streak since June 26, 2025, when it rose for four straight trading days \n</p>\n<p>\n     --Best four day stretch since the four days ending Dec. 6, 2023, when it rose 46.37% \n</p>\n<p>\n     --Up 31.52% month-to-date \n</p>\n<p>\n     --Up 87.12% year-to-date \n</p>\n<p>\n     --Down 63.07% from its all-time closing high of $43.27 on March 24, 2015 \n</p>\n<p>\n     --Up 70.91% from 52 weeks ago (Dec. 9, 2024), when it closed at $9.35 \n</p>\n<p>\n     --Would be a new 52-week closing high \n</p>\n<p>\n     --Up 169.7% from its 52-week closing low of $5.93 on March 3, 2025 \n</p>\n<p>\n     --Traded as high as $16.10; highest intraday level since May 10, 2021, when it hit $16.11 \n</p>\n<p>\n     --Up 27.98% at today's intraday high; largest intraday percent increase since Feb. 22, 2024, when it rose as much as 31.78% \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     All data as of 11:25:07 AM ET \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 08, 2025 11:29 ET (16:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OCUL","symbol_name":"Ocular Therapeutix","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2590935212","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590935212","pubTimestamp":1765211340,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Ocular Therapeutix Inc  is currently at $15.98, up $3.40 or 27.03%. --Would be highest close since May 7, 2021, when it closed at $16.25. --On pace for largest percent increase since Feb. 22, 2024, when it rose 28.99%. --Currently up four consecutive days; up 42.04% over this period. --Longest winning streak since June 26, 2025, when it rose for four straight trading days. --Down 63.07% from its all-time closing high of $43.27 on March 24, 2015. --Up 70.91% from 52 weeks ago , when it closed at $9.35. --Up 169.7% from its 52-week closing low of $5.93 on March 3, 2025. --Traded as high as $16.10; highest intraday level since May 10, 2021, when it hit $16.11. --Up 27.98% at today's intraday high; largest intraday percent increase since Feb. 22, 2024, when it rose as much as 31.78%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OCUL":"Ocular Therapeutix","BK4007":"制药"},"translate_title":"Ocular Therapeutix上涨超过27%，有望创2021年5月以来最高收盘价——Data Talk","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OCUL":1.5},"content_text":"Ocular Therapeutix Inc (OCUL) is currently at $15.98, up $3.40 or 27.03% \n\n\n \n\n\n     --Would be highest close since May 7, 2021, when it closed at $16.25 \n\n\n     --On pace for largest percent increase since Feb. 22, 2024, when it rose 28.99% \n\n\n     --Currently up four consecutive days; up 42.04% over this period \n\n\n     --Longest winning streak since June 26, 2025, when it rose for four straight trading days \n\n\n     --Best four day stretch since the four days ending Dec. 6, 2023, when it rose 46.37% \n\n\n     --Up 31.52% month-to-date \n\n\n     --Up 87.12% year-to-date \n\n\n     --Down 63.07% from its all-time closing high of $43.27 on March 24, 2015 \n\n\n     --Up 70.91% from 52 weeks ago (Dec. 9, 2024), when it closed at $9.35 \n\n\n     --Would be a new 52-week closing high \n\n\n     --Up 169.7% from its 52-week closing low of $5.93 on March 3, 2025 \n\n\n     --Traded as high as $16.10; highest intraday level since May 10, 2021, when it hit $16.11 \n\n\n     --Up 27.98% at today's intraday high; largest intraday percent increase since Feb. 22, 2024, when it rose as much as 31.78% \n\n\n \n\n\n     All data as of 11:25:07 AM ET \n\n\n \n\n\n     Source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 08, 2025 11:29 ET (16:29 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590935212","isCrawlerRequest":true}